Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer-Reference-Cited by-同舟云学术

Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer

Published:2024-06 Issue: Volume: Page:
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Spicer Jonathan D.,Cascone Tina,Wynes Murry W.,Ahn Myung-Ju,Dacic Sanja,Felip Enriqueta,Forde Patrick M.,Higgins Kristin A.,Kris Mark G.,Mitsudomi Tetsuya,Provencio Mariano,Senan Suresh,Solomon Benjamin J.,Tsao Ming Sound,Tsuboi Masahiro,Wakelee Heather A.,Wu Yi-Long,Chih-Hsin Yang James,Zhou Caicun,Harpole David H.,Kelly Karen L.

Funder

AstraZeneca plc

Publisher

Elsevier BV

Reference111 articles.

1. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Rami-Porta;CA Cancer J Clin,2017

2. Current status and future perspectives on neoadjuvant therapy in lung cancer;Blumenthal;J Thorac Oncol,2018

3. AJCC Cancer Staging Manual;Amin,2017

4. Lung cancer stage classification 8th edition;Detterbeck;Chest,2017

5. AJCC Cancer Staging Manual;Edge,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of neoadjuvant immunochemotherapy in resectable stage I-III non-small cell lung cancer: a systematic review and network meta-analysis;Clinical and Translational Oncology;2024-09-09

2. Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario;Current Oncology;2024-08-30

3. Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies;Cancers;2024-08-06